TLR-mediated albuminuria needs TNFα-mediated cooperativity between TLRs present in hematopoietic tissues and CD80 present on non-hematopoietic tissues in mice.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27125280)

Published in Dis Model Mech on April 28, 2016

Authors

Nidhi Jain1, Bhavya Khullar2, Neelam Oswal1, Balaji Banoth1, Prashant Joshi3, Balachandran Ravindran4, Subrat Panda3, Soumen Basak1, Anna George1, Satyajit Rath5, Vineeta Bal6, Shailaja Sopory2

Author Affiliations

1: National Institute of Immunology, New Delhi 110067, India.
2: Pediatric Biology Center, Translational Health Sciences and Technology Institute, Faridabad 121001, National Capital Region, India.
3: Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
4: Institute of Life Sciences, Bhubaneswar, India.
5: National Institute of Immunology, New Delhi 110067, India Pediatric Biology Center, Translational Health Sciences and Technology Institute, Faridabad 121001, National Capital Region, India.
6: National Institute of Immunology, New Delhi 110067, India; and.

Articles cited by this

Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science (1998) 37.15

Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science (2003) 17.57

TLR signaling pathways. Semin Immunol (2004) 9.08

LPS/TLR4 signal transduction pathway. Cytokine (2008) 6.60

Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med (2013) 5.62

The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep (2014) 4.97

Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest (2004) 4.65

Modification of kidney barrier function by the urokinase receptor. Nat Med (2007) 4.01

Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest (1995) 3.43

Nephrotic syndrome in childhood. Lancet (2003) 3.36

A fourth IkappaB protein within the NF-kappaB signaling module. Cell (2007) 3.34

Cell biology and pathology of podocytes. Annu Rev Physiol (2011) 2.42

Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat Med (2010) 2.32

Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Clin J Am Soc Nephrol (2010) 2.24

T-lymphocyte populations and cytokines in childhood nephrotic syndrome. Am J Kidney Dis (2002) 1.88

Elevated levels of tumor necrosis factor-alpha in the nephrotic syndrome in humans. Am J Kidney Dis (1993) 1.87

Role of Toll-like receptor 4 in endotoxin-induced acute renal failure. J Immunol (2004) 1.82

Urinary CD80 excretion increases in idiopathic minimal-change disease. J Am Soc Nephrol (2008) 1.72

Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J Am Soc Nephrol (2007) 1.67

Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways. Cell Signal (2013) 1.56

Glomerular-specific gene excision in vivo. J Am Soc Nephrol (2002) 1.51

Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-κB-dependent pathway. Nephrol Dial Transplant (2011) 1.23

Risk factors for steroid dependency in children with idiopathic nephrotic syndrome. Pediatr Nephrol (2001) 1.21

Idiopathic nephrotic syndrome and atopy: is there a common link? Am J Kidney Dis (2009) 1.13

Nephrotic syndrome in children. Indian J Med Res (2005) 1.12

c-mip impairs podocyte proximal signaling and induces heavy proteinuria. Sci Signal (2010) 1.12

A cell type-specific enhancer in the human B7.1 gene regulated by NF-kappaB. J Exp Med (1996) 1.11

Bacterial lipopeptide triggers massive albuminuria in murine lupus nephritis by activating Toll-like receptor 2 at the glomerular filtration barrier. Immunology (2008) 1.09

Tumor necrosis factor-alpha blocking agent as a treatment for nephrotic syndrome. Pediatr Nephrol (2004) 1.07

Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure. Am J Pathol (1999) 1.06

Minimal change disease: a "two-hit" podocyte immune disorder? Pediatr Nephrol (2010) 1.04

Management of steroid resistant nephrotic syndrome. Indian Pediatr (2009) 1.01

Chitohexaose activates macrophages by alternate pathway through TLR4 and blocks endotoxemia. PLoS Pathog (2012) 1.00

T cells down-regulate macrophage TNF production by IRAK1-mediated IL-10 expression and control innate hyperinflammation. Proc Natl Acad Sci U S A (2014) 0.97

LPS and PAN-induced podocyte injury in an in vitro model of minimal change disease: changes in TLR profile. J Cell Commun Signal (2012) 0.96

Toll-like receptor 3 ligand, polyIC, induces proteinuria and glomerular CD80, and increases urinary CD80 in mice. Nephrol Dial Transplant (2012) 0.95

Tumor necrosis factor-alpha production from mononuclear cells in nephrotic syndrome. Pediatr Nephrol (2003) 0.93

Tumour necrosis factor-α drives Alport glomerulosclerosis in mice by promoting podocyte apoptosis. J Pathol (2011) 0.92

Prognostic values of serum cytokines in septic shock. Intensive Care Med (1994) 0.91

Mechanism of melphalan-induced B7-1 gene expression in P815 tumor cells. J Immunol (2001) 0.89

Monocyte- and endothelial-derived microparticles induce an inflammatory phenotype in human podocytes. Nephron Exp Nephrol (2011) 0.89

Serum from minimal change patients in relapse increases CD80 expression in cultured podocytes. Pediatr Nephrol (2013) 0.88

Acute endotoxemia in mice induces downregulation of megalin and cubilin in the kidney. Kidney Int (2012) 0.88

Tracking changes of lymphocyte subsets and pre-inflammatory mediators in full-term neonates with suspected or documented infection. Scand J Immunol (2011) 0.87

Minimal change disease: a CD80 podocytopathy? Semin Nephrol (2011) 0.87

The costimulatory molecules CD80, CD86 and OX40L are up-regulated in Aspergillus fumigatus sensitized mice. Clin Exp Immunol (2005) 0.86

Inhibition of type I interferon signalling prevents TLR ligand-mediated proteinuria. J Pathol (2013) 0.85

Disorder of fatty acid metabolism in the kidney of PAN-induced nephrotic rats. Am J Physiol Renal Physiol (2012) 0.85

IL-1-like production in adriamycin-induced nephrotic syndrome in the rat. Clin Exp Immunol (1992) 0.84

Tyrosine kinase signaling in kidney glomerular podocytes. J Signal Transduct (2011) 0.83

Serum- and glucocorticoid-inducible kinase 1 in doxorubicin-induced nephrotic syndrome. Am J Physiol Renal Physiol (2008) 0.83

Signal transduction in podocytes--spotlight on receptor tyrosine kinases. Nat Rev Nephrol (2014) 0.82

Filtering new facts about kidney disease. Nat Med (2011) 0.82

Interleukin-8 and tumor necrosis factor-alpha are increased in minimal change disease but do not alter albumin permeability. Am J Nephrol (2003) 0.81

Mouse models of membranous nephropathy: the road less travelled by. Am J Clin Exp Immunol (2013) 0.80

Detection of microalbuminuria: a simple test for prognosis in severe burns. Burns (2012) 0.79

B7-1 expression regulates the hypoxia-driven cytoskeleton rearrangement in glomerular podocytes. Am J Physiol Renal Physiol (2012) 0.79

Point-of-care urine albumin:creatinine ratio is associated with outcome in emergency department patients with sepsis: a pilot study. Acad Emerg Med (2012) 0.79

Immunopathogenesis of idiopathic nephrotic syndrome with relapse. Semin Immunopathol (2014) 0.78

Minimal-change nephrotic syndrome preceding Hodgkin lymphoma by 5 years with expression of tumor necrosis factor alpha in Hodgkin-Reed-Sternberg cells. Hum Pathol (2010) 0.78

Pentamethoxyflavanone regulates macrophage polarization and ameliorates sepsis in mice. Biochem Pharmacol (2014) 0.78

[Features of a cytokine profile in patients with chronic glomerulonephritis with progressive chronic renal failure]. Ter Arkh (2006) 0.76

Serum interleukins and urinary microglobulin in children with idiopathic nephrotic syndrome. East Mediterr Health J (2006) 0.76

Tumor necrosis factor alpha and interleukin 6 in infants with sepsis. Indian Pediatr (2005) 0.76